ArticleCell reports. Medicine2024

CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.

Jean Ching-Yi Tien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.